Bristol-Myers Squibb BMY Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $123.83B.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's market capitalization?
- Bristol-Myers Squibb (BMY) reported market capitalization of $123.83B in Q1 2026.
- How has Bristol-Myers Squibb's market capitalization changed year-over-year?
- Bristol-Myers Squibb's market capitalization decreased by 0.2% year-over-year, from $124.1B to $123.83B.
- What is the long-term trend for Bristol-Myers Squibb's market capitalization?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's market capitalization has grown at a -6.8% compound annual growth rate (CAGR), from $558.17B to $421.42B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.